Inhibition of Akt using MK2206 led to a significant inhibition of tumour growth during the treatment (Fig. 6a) and local inhibition of phospho-mTOR, a key downstream effector of Akt signal (Fig. 6b). Here, AKT1 is linked to neoplasm.